Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 1
1965 1
1977 1
1980 1
1985 2
1986 1
1989 3
1990 2
1991 7
1992 2
1993 3
1994 7
1995 2
1996 3
1997 5
1998 12
1999 15
2000 14
2001 10
2002 13
2003 6
2004 9
2005 6
2006 5
2007 7
2008 6
2009 4
2010 6
2011 9
2012 5
2013 6
2014 6
2015 4
2016 9
2017 10
2018 11
2019 12
2020 15
2021 12
2022 12
2023 15
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

267 results

Results by year

Filters applied: . Clear all
Page 1
Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07.
Kakeji Y, Yoshida K, Kodera Y, Kochi M, Sano T, Ichikawa W, Lee SW, Shibahara K, Shikano T, Kataoka M, Ishiguro A, Ojima H, Sakai Y, Musha N, Takase T, Kimura T, Takeuchi M, Fujii M. Kakeji Y, et al. Among authors: kochi m. Gastric Cancer. 2022 Jan;25(1):188-196. doi: 10.1007/s10120-021-01224-2. Epub 2021 Aug 5. Gastric Cancer. 2022. PMID: 34351555 Clinical Trial.
Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial.
Yoshida K, Kodera Y, Kochi M, Ichikawa W, Kakeji Y, Sano T, Nagao N, Takahashi M, Takagane A, Watanabe T, Kaji M, Okitsu H, Nomura T, Matsui T, Yoshikawa T, Matsuyama J, Yamada M, Ito S, Takeuchi M, Fujii M. Yoshida K, et al. Among authors: kochi m. J Clin Oncol. 2019 May 20;37(15):1296-1304. doi: 10.1200/JCO.18.01138. Epub 2019 Mar 29. J Clin Oncol. 2019. PMID: 30925125 Free PMC article. Clinical Trial.
A Multicenter, Phase II Trial of Schedule Modification for Nab-Paclitaxel in Combination with Ramucirumab for Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer: The B-RAX Trial (JACCRO GC-09).
Kawabata R, Izawa N, Suzuki T, Nagahisa Y, Nishikawa K, Takahashi M, Nakamura M, Ishiguro A, Katsuya H, Hihara J, Manaka D, Negoro Y, Tsuji A, Takahashi T, Kochi M, Azuma M, Kadowaki S, Michimae H, Sunakawa Y, Ichikawa W, Fujii M. Kawabata R, et al. Among authors: kochi m. Target Oncol. 2023 May;18(3):359-368. doi: 10.1007/s11523-023-00961-x. Epub 2023 Apr 15. Target Oncol. 2023. PMID: 37060430 Clinical Trial.
Structural analysis reveals TLR7 dynamics underlying antagonism.
Tojo S, Zhang Z, Matsui H, Tahara M, Ikeguchi M, Kochi M, Kamada M, Shigematsu H, Tsutsumi A, Adachi N, Shibata T, Yamamoto M, Kikkawa M, Senda T, Isobe Y, Ohto U, Shimizu T. Tojo S, et al. Among authors: kochi m. Nat Commun. 2020 Oct 15;11(1):5204. doi: 10.1038/s41467-020-19025-z. Nat Commun. 2020. PMID: 33060576 Free PMC article.
[Oligo-astrocytoma].
Kochi M, Ushio Y. Kochi M, et al. Ryoikibetsu Shokogun Shirizu. 2000;(28 Pt 3):51-3. Ryoikibetsu Shokogun Shirizu. 2000. PMID: 11043178 Review. Japanese. No abstract available.
[Schwannoma].
Nishi T, Kochi M, Ushio Y. Nishi T, et al. Among authors: kochi m. Ryoikibetsu Shokogun Shirizu. 2000;(28 Pt 3):121-7. Ryoikibetsu Shokogun Shirizu. 2000. PMID: 11043201 Review. Japanese. No abstract available.
267 results